Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

Healthcare Biotechnology
"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

TRANSITION THERAPEUTICS INC.
Bullboard Posts
User Avatar Image
(0)
•••
Post by deninsaskon Apr 08, 2008 4:15pm
313 Views
Post# 14950384

AZD-103 Research....Notes from the Keystone

AZD-103 Research....Notes from the Keystone



Bit of an overview of AZD-103 continuing research posted today on AlzForum by Gabrielle Strobel .........

Pretty much just confirms everything Dr. Cruz has been saying all along.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------


Keystone Drug News: Phase 2 Anti-oligomer Sugar Alcohol—How Might It Work?

https://www.alzforum.org/new/detail.asp?id=1792







Bullboard Posts
Dealroom for high-potential pre-IPO opportunities